Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin/Cisplatin vs TAP in Endometrial Cancer
NCT00003691Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Dec 1998
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in endometrial cancer (EC) (2 arms), sponsored by GOG Foundation. Primary endpoint: Overall Survival. Started Dec 1998; status: completed.
02
Drugs
paclitaxel
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00003691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003691.